Correction to: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy

Correction to: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy

An amendment to this paper has been published and can be accessed via the original article.

Bibliographic Details
Main Authors: Alexandra Langlois, Marie-Hélène Lavergne, Hélène Leroux, Kerstin Killer, Pauline Azzano, Louis Paradis, Kathryn Samaan, Jonathan Lacombe-Barrios, Thomas Eiwegger, Julia Upton, Gordon Sussman, Thomas Poder, Benoît Mâsse, Anne Des Roches, Philippe Bégin
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Allergy, Asthma & Clinical Immunology
Online Access:http://link.springer.com/article/10.1186/s13223-020-00435-z

Internet

http://link.springer.com/article/10.1186/s13223-020-00435-z

Similar Items